Prime Therapeutics

primetherapeutics.com · Eagan, United States of America

Prime Therapeutics is a pharmacy benefit manager that partners with health plans, employers, and government programs to manage prescription drug benefits, control pharmacy costs, and improve medication outcomes for members. The company negotiates with drug manufacturers and pharmacies, administers formularies and clinical programs, and processes pharmacy claims on behalf of its clients. It generates revenue primarily through administrative fees, spread pricing, and shared savings arrangements tied to drug spend management.

Revenue
$1B+
Employees
1,001 - 5,000
Founded
1998
Headquarters
Eagan, United States of America

Prime Therapeutics customers on Arbolus

Total customers 9 8 current · 1 former
Reviews growth 9 new reviews since Jan 2026

Customers who reviewed Prime Therapeutics

Seniority of Prime Therapeutics customers

Most people who reviewed Prime Therapeutics hold C-Suite roles (67%), followed by Manager (22%) and Director (11%).

  • C-Suite 67%
  • Manager 22%
  • Director 11%

Customers sample

Operations Ops Manager NPS 8
Data Leader Director NPS 9
Executive C-Suite NPS 7

Employer names and spend open once the report publishes.

What 9 Arbolus experts think of Prime Therapeutics

Overall sentiment: Positive

NPS data ranges from 2 (low) to 10 (high), with a cluster of scores in the 7–9 range, suggesting generally positive customer sentiment and satisfaction. Among those reporting renewal intent, the majority are not sure, although overall stickiness is high, as 100% report being in the 'More Than 1 Year' implementation stage. Most users report consistent and positive experiences after extended usage, though there is some ambivalence about future renewal, primarily from high spenders.

Tell us when the Prime Therapeutics report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

0 Net Promoter Score, from 9 scored reviews
  • Promoters 2
  • Passives 5
  • Detractors 2

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 33%
  • Will renew 1
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Manager 0% 1 answer
  • 2/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers

For people who use Prime Therapeutics

Do you use Prime Therapeutics at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 9 customers of Prime Therapeutics have already contributed

Takes a few minutes. Your identity stays anonymous.